MAZZARINO, Maria Clorinda
 Distribuzione geografica
Continente #
NA - Nord America 3.861
EU - Europa 1.268
AS - Asia 1.103
AF - Africa 187
SA - Sud America 140
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
Totale 6.570
Nazione #
US - Stati Uniti d'America 3.729
SG - Singapore 606
UA - Ucraina 421
CN - Cina 416
IE - Irlanda 375
IT - Italia 164
CI - Costa d'Avorio 132
CA - Canada 127
BR - Brasile 126
RU - Federazione Russa 105
DE - Germania 74
SE - Svezia 50
SN - Senegal 44
IN - India 16
GB - Regno Unito 15
IR - Iran 15
CH - Svizzera 14
FR - Francia 10
EU - Europa 8
NL - Olanda 8
AT - Austria 7
HK - Hong Kong 7
TR - Turchia 7
UZ - Uzbekistan 7
GR - Grecia 6
IQ - Iraq 6
BD - Bangladesh 5
CO - Colombia 5
PL - Polonia 5
AR - Argentina 4
BE - Belgio 4
BG - Bulgaria 4
FI - Finlandia 3
KE - Kenya 3
MA - Marocco 3
MX - Messico 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
LB - Libano 2
PY - Paraguay 2
VN - Vietnam 2
ZA - Sudafrica 2
AO - Angola 1
AZ - Azerbaigian 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
GE - Georgia 1
GH - Ghana 1
JP - Giappone 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
OM - Oman 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
UY - Uruguay 1
Totale 6.570
Città #
Santa Clara 676
Jacksonville 508
Chandler 429
Dublin 375
Singapore 371
Houston 312
Chicago 221
Boardman 184
Abidjan 132
Nanjing 116
Cambridge 111
Lawrence 110
Andover 109
Toronto 107
Des Moines 82
Ashburn 72
San Mateo 69
Catania 56
Grafing 50
Wilmington 45
Dakar 44
Hebei 37
Nanchang 36
Saint Petersburg 31
Jiaxing 26
Shenyang 26
Council Bluffs 22
Civitanova Marche 19
Ottawa 19
Tianjin 18
Beijing 16
Changsha 15
Ardabil 14
Florence 14
Leawood 13
Los Angeles 12
Bremen 11
Augusta 10
Norwalk 10
Kunming 9
Monmouth Junction 9
Ningbo 9
Hangzhou 8
Jinan 8
Rio de Janeiro 8
São Paulo 8
Moscow 7
Falls Church 6
San Francisco 6
Seattle 6
The Dalles 6
Den Haag 5
Guangzhou 5
Hong Kong 5
Misterbianco 5
Brussels 4
Changchun 4
Dearborn 4
Kiev 4
Viagrande 4
Amsterdam 3
Ann Arbor 3
Baghdad 3
Bangalore 3
Curitiba 3
Lausanne 3
Liberty Lake 3
Mountain View 3
Nairobi 3
Porto Alegre 3
Shanghai 3
Taizhou 3
Washington 3
Zhengzhou 3
Barbacena 2
Belo Horizonte 2
Bragança Paulista 2
Brasília 2
Campinas 2
Caxias do Sul 2
Dong Ket 2
Erbil 2
Fremont 2
Goiânia 2
Helsinki 2
Lahore 2
Maletto 2
Milan 2
Munich 2
Padova 2
Palermo 2
Priolo Gargallo 2
Pune 2
Rondonópolis 2
Serra 2
Sousa 2
Tappahannock 2
Tashkent 2
Trecastagni 2
Abu Dhabi 1
Totale 4.751
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 298
The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance. 296
Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients 117
Absence of BRAF gene mutation in non-melanoma skin tumors 95
BRAF G469S mutation as indicator of neoplastic transformation in workers with UV exposure 89
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene 87
Beta-2-glycoprotein I is growth regulated and plays a role as survival factor for hepatocytes 86
Analysis of hepatitis C virus infection among health-care workers: an observational study 84
PARTIAL LIPODYSTROPHY - IMMUNOLOGICAL STUDIES IN A SICILIAN GIRL 78
All trans retinoic acid sensitizes colon cancer cells to hyperthermia cytotoxic effects 78
Proinflammatory circulating molecules in peripheral arterial disease 74
Analysis of G(-174) CIL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease 73
Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients 72
Vitamin D3: an ever green molecule 72
Detection of BRAF gene mutation in primary choroidal melanoma tissue 72
Analysis of BRAF mutation in primary and metastatic melanoma 72
Advances in targeting signal transduction pathways. 72
B-cell neoplasia in the context of HCV infection: A distinct entity? 72
Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus 72
Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract 71
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 71
Analysis of MMP-9 gene polymorphism 1562C/T in patients suffering from systemic sclerosis with and without ulcers 70
Cell death in human acute myelogenous leukemic cells induced by pyrrolidinedithiocarbamate 69
Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression 68
IL-2 RECEPTORS, NK AND LAK CYTOTOXICITY OF LYMPHOCYTES IN BREAST-CARCINOMA DURING PROLONGED THYMOPENTIN THERAPY 67
Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study 67
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease 67
GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG 67
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age 65
Defective function of the fas apoptotic pathway in type 1 diabetes mellitus correlates with age at onset 64
S100A7: A rAMPing up AMP molecule in psoriasis 64
Evaluation of circulating CD4⁺CD25⁺ and liver-infiltrating Foxp3⁺ cells in HCV-associated liver disease 64
Analysis of matrix metalloproteinase-9 gene polymorphism-1562 C/T in patients suffering from systemic sclerosis with and without ulcers 64
Co-regulated expression of matrix metalloproteinase-2 and transforming growth factor-beta in melanoma development and progression 62
Role of Hypoxia and Autophagy in MDA-MB-231 Invasiveness 62
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 62
High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test 62
Jagged-1 expression is downregulated in skin from biologic-treated psoriatic patients 62
CD155/Neel-5 immunolocallization in melanocytic skin lesions 62
Effect of alpha-interferon on natural killer cell activity and lymphocyte subsets in thalassemia patients with chronic hepatitis C 61
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 61
Computational Evaluation of Yin Yang 1 Transcript Levels in the Spectrum of B-cell Neoplasia 61
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 61
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance 61
Role of BRAF mutations in hematopoietic malignancies and the induction of cytokine-independence-synergy with PI3K/Akt pathway 60
IL2 and its receptors in elderly subjects on hemodialysis 60
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 60
Persistent high plasma levels of interleukins 18 and 4 in children with recurrent infections of the upper respiratory tract 60
Regulation of drug and immune resistance by YY1 in cancer 59
Sensitization of cancer stem cells based on inhibiting key signal transduction pathways 59
Biologically induced improvement of PASI score is associated with a decline of S100A7 expression in psoriatic skin lesions. A preliminary immunohistochemical study 59
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 59
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 58
Analysis of osteopontin and matrix metalloproteinase-9 in prostate cancer 58
Genetic polymorphisms of FOXP3 in Italian patients with systemic sclerosis 57
Behavior of complement and anti-complement factors in the course of hepatic regeneration and degeneration 57
IL-18 nelle infezioni virali ricorrenti in età pediatrica 56
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 56
Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients 55
Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease 54
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation 54
Contribution of Immunohistochemistry in Revealing S100A7/JAB1 Colocalization in Psoriatic Epidermal Keratinocyte 54
CIRCULATING IMMUNOCOMPLEXES AND LARYNGEAL CARCINOMA 53
Rituximab for treatment of lymphoproliferative disorders associated with hepatitis C virus (HCV) infection 53
Immunohistocemical localization of NECL-5 in melanocytic skin lesions. Preliminary observations 53
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway 53
Biological therapy induces expression changes in Notch pathway in psoriasis 52
Novel NO-donating compound GIT-27NO possesses strong tumoricidal capacity in vitro and in vivo 51
Isoproterenol treatment modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) expression in rat parotid gland 50
CD155/Necl-5 immunolocalization in melanocytic skin lesions 50
S100A7, Jab1, and p27 kip1 expression in psoriasis and S100A7 CRISPR-activated human keratinocyte cell line 50
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection 49
Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis 49
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer 49
Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer 48
Uterine cervical carcinoma: Role of matrix metalloproteinases (Review) 48
Modulation of Chitotriosidase During Macrophage Differentiation 48
Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients 48
Effects of adalimumab, etanercept and ustekinumab on the expression of psoriasin (S100A7) in psoriatic skin 48
Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland 47
Insight into the role of microRNAs in brain tumors (review) 47
MAPK and AKT pathways are activated in melanoma by BRAF, NRAS and PIK3CA mutations 46
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappa B inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes 45
Immunolocalization of FOXP3 in HCV-infected liver biopsies. Preliminary observations 45
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health 45
Lack of association of rs3761549 and rs5902434 polymorphisms of FOXP3 gene with risk of systemic sclerosis in the Italian population: A case-control study 45
Long pentraxin 3: a marker of inflammation in untreated psoriatic patients 44
High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation 44
Osteopontin and matrix metalloptroteinase-9 as markers of early detection of prostate cancer development 44
Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barre syndrome 44
Jagged-1/Notch-1/Hes-1 pathway in psoriatic patients: effects of biological therapy 43
Preoperative rIL-2 treatment in renal cancer: Early and late effects on lymphocyte subsets and proliferation, NK activity, IL-6 in vivo and in vitro production 43
S100A7 in psoriasis: Immunodetection and activation by CRISPR technology 43
Expression and localization of prominin-1 in isoproterenol-treated rat parotid gland 42
Venous stasis causes release of interleukin 1β (IL - 1β), interleukin 6 (IL – 6) and tumor necrosis factor alpha (TNFα) by monocite macrophage 42
FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population 41
Prognostic significance of YY1 in High Grade Lymphomas 40
Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma 40
Frequency of bcl-2/IgH translocation in patients with non-Hodgkin's lymphoma and chronic hepatitis C virus infection 39
IL-6-174 G > C and MMP-9-1562 C > T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients. 37
Totale 6.367
Categoria #
all - tutte 24.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.008


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 0 0 0 0 0 0 0 0 0 0 71 14
2020/2021769 8 57 102 2 173 9 100 0 109 0 186 23
2021/2022815 105 110 0 8 129 6 116 23 76 0 16 226
2022/20231.217 121 56 24 109 133 217 2 208 283 14 39 11
2023/2024505 22 75 24 41 11 122 1 54 9 7 86 53
2024/20251.937 21 462 100 50 515 291 30 84 199 183 2 0
Totale 6.707